Human monoclonal antibodies encoded by the V4-34 gene segment show cold agglutinin activity and variable multireactivity which correlates with the predicted charge of the heavy-chain variable region

Immunology
S J ThorpeK M Thompson

Abstract

We have characterized the reactivities of a panel of V4-34-encoded human IgM monoclonal antibodies (mAb) which bind the erythrocyte Rh D antigen, derived from an immunized individual. These were compared with the specificities of V4-34-encoded autoantibodies with I/i reactivity produced from patients with cold agglutinin disease (CAD), and other V4-34-encoded autoantibodies. The antibodies were evaluated for cold agglutinin activity using haemagglutination tests, immunofluorescence microscopy for reactivity with tissue components, and in solid phase radiobinding assays with purified antigens. We found that (i) cold agglutinin activity was a property of all the V4-34-encoded mAb (ii) the cold agglutinins from CAD patients were generally monospecific for I/i whereas most of the anti-D and the other V4-34-encoded mAb displayed multireactive properties, frequently binding to strongly acidic antigens (iii) computation of the net charge of the heavy-chain V regions showed that the multireactive mAb were generally more positively charged than the monospecific cold agglutinins, which could contribute to their multireactive phenotype. The involvement of charge interactions was further indicated by the effects of pH and ionic strength on...Continue Reading

References

Oct 1, 1987·American Journal of Hematology·W PruzanskiL C Lui
Jul 1, 1995·Scandinavian Journal of Immunology·M BørretzenK M Thompson
Dec 1, 1993·The Journal of Clinical Investigation·L C JefferiesL E Silberstein

❮ Previous
Next ❯

Citations

Apr 13, 2001·Journal of Molecular Recognition : JMR·J J MarchalonisA B Edmundson
Nov 26, 2002·Journal of Molecular Recognition : JMR·Parisa AsvadiRobert L Raison
Jan 6, 2005·Springer Seminars in Immunopathology·Eric C B MilnerIñaki Sanz
May 17, 2005·Journal of Ethnopharmacology·Ho-Jeong NaHyung-Min Kim
Oct 31, 2001·Molecular Immunology·S S Saini, A Kaushik
Apr 27, 2000·Transfusion Medicine Reviews·A BlancherW W Socha
Apr 20, 2000·Transfusion Science·K N Potter
Jun 3, 1999·British Journal of Haematology·N C Hughes-JonesW H Ouwehand
Jan 17, 2009·The Journal of Investigative Dermatology·Nataly Manjarrez-OrduñoIñaki Sanz
Sep 26, 2009·Transfusion·Daniel JanvierPhilippe Bierling
Oct 14, 2008·Journal of Immunological Methods·Ramon F MontanoKoteswara R Chintalacharuvu
Nov 25, 2004·Hematology·Wendell F RosseAlan D Schreiber
Mar 6, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Noa Simchoni, Charlotte Cunningham-Rundles
Sep 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kathleen N PotterBrian J Sutton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.